Development of highly efficient niosomal systems for co-delivery of drugs and genes to treat breast cancer in vitro and in vivo

Development of highly efficient niosomal systems for co-delivery of drugs and genes to treat breast cancer in vitro and in vivo

Abstract In this paper, we step forward in optimizing the efficiency of niosomal systems for carrying curcumin and miR-34a as single-/co-delivery to treat breast cancer. Curcumin, via regulation of p53 protein, affects the molecular signaling pathways and leads to cell death. Likewise, miRNAs, via a...

Full description

Bibliographic Details
Main Authors: Najmeh Alsadat Abtahi, Seyed Morteza Naghib, Fatemeh Haghiralsadat, Mohammadmahdi Akbari Edgahi
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Cancer Nanotechnology
Subjects:
Drug delivery
Curcumin
miRNA
Nanoniosome
Codelivery
Breast cancer
Online Access:https://doi.org/10.1186/s12645-022-00135-w

Internet

https://doi.org/10.1186/s12645-022-00135-w

Similar Items